FIELD: medicine.
SUBSTANCE: invention relates to a method of treating an autoimmune disorder. The following provided: a method of treating a subject suffering from an autoimmune disorder, comprising administering to the said subject in need thereof a therapeutically effective amount of a PRMT5 inhibitor, wherein PRMT5 inhibitor is (1S,2S,3S,5R)-3-((6-(difluoromethyl)- 5-fluoro-1,2,3,4-tetrahydroiso-quinolin-8-yl)oxy)-5-(4-methyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-cyclopentan-1,2-diol:
or a pharmaceutically acceptable salt thereof, wherein the said subject is administered a therapeutically effective amount of 0.5 mg to 120 mg.
EFFECT: use of the method is effective for the treatment of an autoimmune disorder such as psoriasis in particular.
21 cl, 1 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| POLYMORPHOUS FORM OF THE MONOPOSPHATE HYDRATE SALT OF THE KNOWN TETRAHYDROISOQUINOLINE DERIVATIVE | 2020 |
|
RU2801355C2 |
| SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS | 2017 |
|
RU2712944C1 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| TREATMENT OF HYDRADENITIS WITH JAK INHIBITORS | 2020 |
|
RU2805595C1 |
| COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
| SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
| 5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
| COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE | 2013 |
|
RU2654482C2 |
| PIPERIDINE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2016 |
|
RU2730508C2 |
| NLRP3 INFLAMMASOME INHIBITORS | 2020 |
|
RU2826735C2 |
